MAXIMIZING ONCOLOGY INVESTIGATE WITH BUILT-IN KRAS ASSAY PRODUCTS AND SERVICES AND RAS ASSAYS

during the speedily evolving discipline of oncology analysis, correct and successful mutation screening is important for acquiring qualified therapies. The KRAS solutions Platform plays a pivotal function in this landscape by offering in depth answers for KRAS mutation profiling and analysis. KRAS mutations, located in close to ninety five% of RAS-